Browse Category

SWX:ROP 10 June 2026

Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

Roche Holding Ltd. participation certificates listed on SIX traded up 1.07% at CHF 322.20 late Wednesday morning. Investors were eyeing a new $2.3 billion deal with Nurix Therapeutics, bringing Roche a late-stage blood-cancer asset. The stock line now trades as ROP after the company switched from the former ROG Genussscheine in March. Roche’s bearer shares are listed as RO.

Google Preferred Source

TS2 Tech on Google
Follow TS2 Tech

Choose TS2 Tech as a preferred source or open our publication in Google News.

Stock Market Today

  • GoDaddy Q2 2026 Earnings Preview: Revenue, AI Product Momentum Fuel Optimism
    July 28, 2026, 2:34 PM EDT. GoDaddy (GDDY) will announce Q2 2026 results on July 30, forecasting revenue in the $1.285 billion to $1.305 billion range, reflecting approximately 6% growth. Consensus for earnings per share stands at $1.72, up 21.99% from a year earlier. The performance is supported by low-double-digit revenue gains in Applications & Commerce, the success of AI-driven offerings including Airo AI Builder, and enhancements to its AI-powered Websites + Marketing suite. Improved operational efficiency points to further margin gains, despite ongoing competition.